e-Drug3D

2132

LEVACETYLLEUCINE


INN
LEVACETYLLEUCINE

cas 1188-21-2
CLASS

NERVOUS SYSTEM
TREATMENT OF NEUROLOGICAL MANIFESTATIONS OF NIEMANN-PICK DISEASE TYPE C (NPC)

ROUTE (list)

ORAL

ATC code

PK parameters

Tmax 1 HOUR
VD 253 LITER
Cl 139 LITER / HOUR
t1/2 1 HOUR

Solubility

SLIGHTLY SOLUBLE IN WATER


Target

-

DrugCentral

-

Download SDF file N-Acetyl-L-leucine

Formula:
C8H15NO3

Calculated chemical properties:

MW 172.20
NB_atoms 12
XLogP -0.71
PSA 63.675
NB_HD 1
NB_HA 4
fsp3 0.75
Lipinski(0=no;1=yes) 1

FDA
NDA 219132 (pdf not found) INN (LEVACETYLLEUCINE) AQNEURSA (INTRABIO) APPROVAL= AP YEAR= 2024 NEWMOLECULARENTITY

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL